192 related articles for article (PubMed ID: 11773086)
1. Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.
Chu CM; Yeh CT; Lee CS; Sheen IS; Liaw YF
J Clin Microbiol; 2002 Jan; 40(1):16-21. PubMed ID: 11773086
[TBL] [Abstract][Full Text] [Related]
2. Universal emergence of precore mutant hepatitis B virus along with seroconversion to anti-HBe irrespective of subsequent activity of chronic hepatitis B.
Koh KC; Lee HS; Kim CY
Korean J Intern Med; 1994 Jul; 9(2):61-6. PubMed ID: 7865490
[TBL] [Abstract][Full Text] [Related]
3. Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers.
Karasawa T; Shirasawa T; Okawa Y; Kuramoto A; Shimada N; Aizawa Y; Zeniya M; Toda G
J Gastroenterol; 1997 Oct; 32(5):611-22. PubMed ID: 9349986
[TBL] [Abstract][Full Text] [Related]
4. Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti-HBe.
Bläckberg J; Kidd-Ljunggren K
J Med Virol; 2000 Feb; 60(2):107-12. PubMed ID: 10596007
[TBL] [Abstract][Full Text] [Related]
5. Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels.
Bozdayi AM; Bozkaya H; Türkyilmaz AR; Sarýodlu M; Cetinkaya H; Karayalçin S; Yurdaydin C; Uzunalimoğlu O
J Clin Virol; 2001 Apr; 21(1):91-101. PubMed ID: 11255102
[TBL] [Abstract][Full Text] [Related]
6. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion.
Maruyama T; Kuwata S; Koike K; Iino S; Yasuda K; Yotsuyanagi H; Moriya K; Maekawa H; Yamada H; Shibata Y; Milich DR
Hepatology; 1998 Jan; 27(1):245-53. PubMed ID: 9425944
[TBL] [Abstract][Full Text] [Related]
7. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
Loriot MA; Marcellin P; Talbodec N; Guigonis V; Gigou M; Boyer N; Bezeaud A; Erlinger S; Benhamou JP
Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659
[TBL] [Abstract][Full Text] [Related]
8. Precore mutant hepatitis B virus and outcome of chronic infection and hepatitis in hepatitis B e antigen-positive children.
Barbera C; Calvo P; Coscia A; Perugini L; Dastoli G; Randone A; Bonino F; Brunetto MR
Pediatr Res; 1994 Sep; 36(3):347-50. PubMed ID: 7528908
[TBL] [Abstract][Full Text] [Related]
9. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
Maruyama T; Mitsui H; Maekawa H; Yamada H; Hirayama M; Iino S; Yasuda K; Koike K; Kimura S; Milich DR
Am J Gastroenterol; 2000 Oct; 95(10):2894-904. PubMed ID: 11051365
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus precore mutations and HBeAg negative reactivation of chronic hepatitis B after interferon therapy.
Talbodec N; Loriot MA; Gigou M; Guigonis V; Boyer N; Bezeaud A; Erlinger S; Benhamou JP; Marcellin P
Liver; 1995 Apr; 15(2):93-8. PubMed ID: 7540713
[TBL] [Abstract][Full Text] [Related]
11. Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy.
Takeda K; Akahane Y; Suzuki H; Okamoto H; Tsuda F; Miyakawa Y; Mayumi M
Hepatology; 1990 Dec; 12(6):1284-9. PubMed ID: 2258145
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of hepatitis B virus precore mutant in hepatitis type B.
Ichikawa T; Takagi H; Kinoshita M; Shimoda R; Nagamine T; Mori M
Tohoku J Exp Med; 1998 Dec; 186(4):323-33. PubMed ID: 10328164
[TBL] [Abstract][Full Text] [Related]
13. The impact of hepatitis B virus precore/core gene carboxyl terminal mutations on viral biosynthesis and the host immune response.
Wu JF; Ni YH; Chen HL; Hsu HY; Chang MH
J Infect Dis; 2014 May; 209(9):1374-81. PubMed ID: 24273041
[TBL] [Abstract][Full Text] [Related]
14. Clinical and virological characteristics of chronic hepatitis B with concurrent hepatitis B E antigen and antibody detection.
Wang J; Zhou B; Lai Q; Wang Y; Shen G; Wang Z; Chen J; Hou J
J Viral Hepat; 2011 Sep; 18(9):646-52. PubMed ID: 20636332
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis may precede the occurrence of precore region mutation in hepatitis B virus genome during infection in young carriers.
Nguyen XT; Fukuda R; Fukumoto S
J Med Virol; 1994 Oct; 44(2):200-5. PubMed ID: 7852961
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
[TBL] [Abstract][Full Text] [Related]
17. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.
Fattovich G; Rugge M; Brollo L; Pontisso P; Noventa F; Guido M; Alberti A; Realdi G
Hepatology; 1986; 6(2):167-72. PubMed ID: 3957228
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B e antigen-negative chronic hepatitis B patients: spontaneous seroconversion and interferon-induced seroconversion.
Karasawa T; Aizawa Y; Zeniya M; Kuramoto A; Shirasawa T; Toda G
J Med Virol; 1995 Apr; 45(4):373-80. PubMed ID: 7666040
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany.
Knöll A; Rohrhofer A; Kochanowski B; Wurm EM; Jilg W
J Med Virol; 1999 Sep; 59(1):14-8. PubMed ID: 10440802
[TBL] [Abstract][Full Text] [Related]
20. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
Ferns RB; Naoumov NV; Gilson RJ; Tedder RS
J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
